Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
Stroke Research and Therapy
Release date: 2023
Column Information

Stroke is the second leading cause of death and the leading disability worldwide. One in four people over age 25 will have a stroke in their lifetime. Endovascular thrombectomy is the most effective reperfusion treatment in ischemic stroke due to large vessel occlusion, However, there are still unanswered questions in selecting eligible patients thrombectomy with significant inequality issues in accessing of stroke care. Although management of vascular risk factors remains extremely important in stroke prevention, the discoveries in stroke genetics would enable the identification of high-risk individuals before the emergence of vascular risk factors and potential new treatment targets. There are over 101 million stroke survivals globally. Person-centered, collaborative rehabilitation still awaits more studies, especially on post-stroke cognitive rehab. This Column will focus on stroke research and therapy. 

Published Paper (2 Papers)
SHORT COMMUNICATION

Subclinical atrial fibrillation in embolic stroke of undetermined source: Management and stroke recurrence

Luca Masotti, Elisa Grifoni, Alessia Baglini, Teresa Sansone, ... Valentina Francolini
Advanced Neurology 2024, 3(1), 2287 https://doi.org/10.36922/an.2287
(This article belongs to the Special Issue Advances in stroke research and therapy)
Back to top
Advanced Neurology, Electronic ISSN: 2810-9619 Published by AccScience Publishing